DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,147,838 | +3.4% | 16,718 | +0.0% | 0.31% | +10.5% |
Q2 2023 | $4,011,175 | -5.2% | 16,713 | -0.5% | 0.28% | -5.8% |
Q1 2023 | $4,232,535 | +2.9% | 16,793 | +8.4% | 0.29% | -10.9% |
Q4 2022 | $4,112,417 | -19.2% | 15,494 | -21.4% | 0.33% | -15.2% |
Q3 2022 | $5,088,000 | -27.6% | 19,700 | -28.9% | 0.39% | -16.7% |
Q2 2022 | $7,023,000 | -11.6% | 27,701 | +2.2% | 0.47% | +18.5% |
Q1 2022 | $7,947,000 | -26.1% | 27,093 | -17.1% | 0.39% | -17.7% |
Q4 2021 | $10,750,000 | +7.7% | 32,675 | -0.4% | 0.48% | +3.0% |
Q3 2021 | $9,984,000 | +12.5% | 32,796 | -0.8% | 0.46% | +21.1% |
Q2 2021 | $8,871,000 | +18.8% | 33,055 | -0.3% | 0.38% | +10.7% |
Q1 2021 | $7,465,000 | +7.8% | 33,167 | +6.3% | 0.35% | -15.6% |
Q4 2020 | $6,928,000 | +2.2% | 31,189 | -1.0% | 0.41% | +0.7% |
Q3 2020 | $6,782,000 | +21.9% | 31,499 | +0.1% | 0.41% | +17.9% |
Q2 2020 | $5,565,000 | +27.2% | 31,474 | -0.4% | 0.35% | +16.5% |
Q1 2020 | $4,374,000 | -8.4% | 31,599 | +1.6% | 0.30% | +32.0% |
Q4 2019 | $4,773,000 | +832.2% | 31,103 | +777.6% | 0.22% | +878.3% |
Q3 2019 | $512,000 | -40.1% | 3,544 | -40.8% | 0.02% | -30.3% |
Q2 2019 | $855,000 | +305.2% | 5,983 | +179.4% | 0.03% | +371.4% |
Q2 2018 | $211,000 | -98.8% | 2,141 | -98.9% | 0.01% | -97.2% |
Q2 2017 | $17,050,000 | +0.7% | 202,039 | +2.1% | 0.25% | -6.0% |
Q1 2017 | $16,930,000 | +49.9% | 197,942 | +36.4% | 0.27% | +34.8% |
Q4 2016 | $11,294,000 | -2.4% | 145,088 | -1.7% | 0.20% | -2.5% |
Q3 2016 | $11,568,000 | -31.0% | 147,579 | -11.1% | 0.20% | -21.9% |
Q2 2016 | $16,763,000 | +6.8% | 165,979 | +0.3% | 0.26% | -0.4% |
Q1 2016 | $15,694,000 | -6.7% | 165,444 | -8.7% | 0.26% | -0.4% |
Q4 2015 | $16,828,000 | -0.7% | 181,182 | -8.9% | 0.26% | -10.0% |
Q3 2015 | $16,945,000 | +5.5% | 198,864 | +5.9% | 0.29% | +24.9% |
Q2 2015 | $16,066,000 | +5.0% | 187,706 | +4.1% | 0.23% | +1.7% |
Q1 2015 | $15,307,000 | -11.4% | 180,299 | -10.6% | 0.23% | -11.2% |
Q4 2014 | $17,286,000 | -12.5% | 201,690 | -22.4% | 0.26% | -10.1% |
Q3 2014 | $19,745,000 | +4.4% | 259,873 | +8.2% | 0.29% | 0.0% |
Q2 2014 | $18,915,000 | +44.5% | 240,244 | +37.7% | 0.29% | +36.7% |
Q1 2014 | $13,086,000 | -11.2% | 174,485 | -8.6% | 0.21% | -18.3% |
Q4 2013 | $14,744,000 | +46.6% | 190,986 | +31.6% | 0.26% | +36.7% |
Q3 2013 | $10,059,000 | -2.1% | 145,103 | -10.6% | 0.19% | -16.4% |
Q2 2013 | $10,277,000 | – | 162,361 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |